RETRACTED: A pilot study of the effect of transcranial magnetic stimulation treatment on cognitive dysfunction associated with <scp>post COVID‐19 condition</scp>

Noda, Yoshihiro; Sato, Akiko; Fujii, Kyoshiro; Nagano, Yasuhiro; Iwasa, Mio; Hirahata, Koichi; Kitahata, Ryosuke; Osawa, Ryota

doi:10.1111/pcn.13527

Cited by 3 publications

(2 citation statements)

References 10 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Thirteen articles in journals with the highest impact factors (>10) were analyzed in more detail to determine the explanation for the retraction (Table 4). [6][7][8][9][10][11][12][13][14][15][16][17][18] The impact factor for these journals ranged from 10.6 to 168.9. The most frequent reason for retraction was either concerns about data validity (n = 3) or unreliable results (n = 3).…”

Section: Resultsmentioning

confidence: 99%

Analysis of the Types of Retracted COVID-19 Articles Published in PubMed-Listed Journals

Alexander,

Yang,

Peterson

et al. 2024

Southern Medical Journal

View full text Add to dashboard Cite

Section: Resultsmentioning

confidence: 99%

Analysis of the Types of Retracted COVID-19 Articles Published in PubMed-Listed Journals

Alexander,

Yang,

Peterson

et al. 2024

Southern Medical Journal

View full text Add to dashboard Cite

“…TACS, among other NIBS methods [ 142 , 143 ], was used experimentally in amelioration of cognitive symptoms of PASC due to a rising number of these cases. Its potential mechanism of action might be working against neuroinflammation and promoting protein clearance, seen with gamma-tACS in AD [ 91 , 93 ].…”

Section: Discussionmentioning

confidence: 99%

Transcranial alternating current stimulation in affecting cognitive impairment in psychiatric disorders: a review

Biačková,

Adamová,

Klírová

2023

Eur Arch Psychiatry Clin Neurosci

View full text Add to dashboard Cite

Transcranial alternating current stimulation (tACS) is a non-invasive brain stimulation method that, through its manipulation of endogenous oscillations, can affect cognition in healthy adults. Given the fact that both endogenous oscillations and cognition are impaired in various psychiatric diagnoses, tACS might represent a suitable intervention. We conducted a search of Pubmed and Web of Science databases and reviewed 27 studies where tACS is used in psychiatric diagnoses and cognition change is evaluated. TACS is a safe and well-tolerated intervention method, suitable for multiple-sessions protocols. It can be administered at home, individualized according to the patient'’s anatomical and functional characteristics, or used as a marker of disease progression. The results are varying across diagnoses and applied protocols, with some protocols showing a long-term effect. However, the overall number of studies is small with a great variety of diagnoses and tACS parameters, such as electrode montage or used frequency. Precise mechanisms of tACS interaction with pathophysiological processes are only partially described and need further research. Currently, tACS seems to be a feasible method to alleviate cognitive impairment in psychiatric patients; however, a more robust confirmation of efficacy of potential protocols is needed to introduce it into clinical practise.

show abstract

Research evidence on the management of the cognitive impairment component of the post-COVID condition: a qualitative systematic review

Melillo,

Perrottelli,

Caporusso

et al. 2024

Eur. Psychiatr.

View full text Add to dashboard Cite

Background Cognitive impairment (CI) is one of the most prevalent and burdensome consequences of COVID-19 infection, which can persist up to months or even years after remission of the infection. Current guidelines on post-COVID CI are based on available knowledge on treatments used for improving CI in other conditions. The current review aims to provide an updated overview of the existing evidence on the efficacy of treatments for post-COVID CI. Methods A systematic literature search was conducted for studies published up to December 2023 using three databases (PubMed–Scopus–ProQuest). Controlled and noncontrolled trials, cohort studies, case series, and reports testing interventions on subjects with CI following COVID-19 infection were included. Results After screening 7790 articles, 29 studies were included. Multidisciplinary approaches, particularly those combining cognitive remediation interventions, physical exercise, and dietary and sleep support, may improve CI and address the different needs of individuals with post-COVID-19 condition. Cognitive remediation interventions can provide a safe, cost-effective option and may be tailored to deficits in specific cognitive domains. Noninvasive brain stimulation techniques and hyperbaric oxygen therapy showed mixed and preliminary results. Evidence for other interventions, including pharmacological ones, remains sparse. Challenges in interpreting existing evidence include heterogeneity in study designs, assessment tools, and recruitment criteria; lack of long-term follow-up; and under-characterization of samples in relation to confounding factors. Conclusions Further research, grounded on shared definitions of the post-COVID condition and on the accurate assessment of COVID-related CI, in well-defined study samples and with longer follow-ups, is crucial to address this significant unmet need.

show abstract

RETRACTED: A pilot study of the effect of transcranial magnetic stimulation treatment on cognitive dysfunction associated with post COVID‐19 condition

Abstract: Long-COVID is defined as having physical symptoms such as chronic fatigue, memory impairment, poor concentration, and depressed mood that persist for at least 3 months apart from acute respiratory symptoms.

Cited by 3 publications

References 10 publications

Analysis of the Types of Retracted COVID-19 Articles Published in PubMed-Listed Journals

Analysis of the Types of Retracted COVID-19 Articles Published in PubMed-Listed Journals

Transcranial alternating current stimulation in affecting cognitive impairment in psychiatric disorders: a review

Research evidence on the management of the cognitive impairment component of the post-COVID condition: a qualitative systematic review

Contact Info

Product

Resources

About